Astellas Pharma Inc
Clinical trials sponsored by Astellas Pharma Inc, explained in plain language.
-
First patients dosed in groundbreaking trial targeting common cancer driver
Disease control OngoingThis is the first time researchers are giving the experimental drug ASP4396 to people. The study aims to find a safe dose and understand how the body processes it in adults with advanced solid tumors that have a specific genetic change called KRAS G12D. Participants have cancer t…
Phase: PHASE1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for leukemia patients who run out of options
Disease control OngoingThis study tested whether a new targeted pill (gilteritinib) works better than standard chemotherapy for adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to first treatment. The goal was to see if the new drug helps patients live long…
Phase: PHASE3 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Year-Long trial tests safety of new hot flash pill for menopausal women
Symptom relief OngoingThis study aims to confirm the long-term safety of fezolinetant, a non-hormonal medication for menopausal hot flashes, in Japanese women. Over 270 participants will take either the drug or a placebo daily for up to one year while doctors monitor their health. The goal is to gathe…
Phase: PHASE3 • Sponsor: Astellas Pharma Inc • Aim: Symptom relief
Last updated Mar 04, 2026 15:29 UTC